| Date | Time | Source | Headline | Symbol | Company |
| 06/11/2024 | 10:30AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:OLK | Olink Holding AB |
| 06/11/2024 | 9:00AM | GlobeNewswire Inc. | Notice to attend the Extra General Meeting of Olink Holding AB (publ) | NASDAQ:OLK | Olink Holding AB |
| 06/06/2024 | 2:00AM | GlobeNewswire Inc. | Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence | NASDAQ:OLK | Olink Holding AB |
| 05/30/2024 | 8:00AM | GlobeNewswire Inc. | Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis | NASDAQ:OLK | Olink Holding AB |
| 05/13/2024 | 6:04AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:OLK | Olink Holding AB |
| 05/13/2024 | 6:00AM | GlobeNewswire Inc. | Olink reports first quarter 2024 financial results | NASDAQ:OLK | Olink Holding AB |
| 04/19/2024 | 4:05PM | GlobeNewswire Inc. | Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 | NASDAQ:OLK | Olink Holding AB |
| 04/02/2024 | 8:00AM | GlobeNewswire Inc. | Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease | NASDAQ:OLK | Olink Holding AB |
| 03/25/2024 | 8:00AM | GlobeNewswire Inc. | Olink reports fourth quarter and full year 2023 financial results | NASDAQ:OLK | Olink Holding AB |
| 03/25/2024 | 8:00AM | GlobeNewswire Inc. | Olink publishes 2023 annual report | NASDAQ:OLK | Olink Holding AB |
| 03/15/2024 | 8:00AM | GlobeNewswire Inc. | Notice to attend the Annual General Meeting of Olink Holding AB (publ) | NASDAQ:OLK | Olink Holding AB |
| 03/08/2024 | 8:00AM | GlobeNewswire Inc. | Olink announces change of date for Annual General Meeting | NASDAQ:OLK | Olink Holding AB |
| 03/06/2024 | 8:43AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:OLK | Olink Holding AB |
| 03/01/2024 | 4:45PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:OLK | Olink Holding AB |
| 02/20/2024 | 4:45PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:OLK | Olink Holding AB |
| 01/04/2024 | 4:45PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:OLK | Olink Holding AB |
| 12/22/2023 | 4:47PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:OLK | Olink Holding AB |
| 12/15/2023 | 4:45PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:OLK | Olink Holding AB |
| 11/15/2023 | 7:03AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:OLK | Olink Holding AB |
| 11/15/2023 | 7:00AM | GlobeNewswire Inc. | Olink reports third quarter 2023 financial results | NASDAQ:OLK | Olink Holding AB |
| 11/13/2023 | 5:12PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:OLK | Olink Holding AB |
| 11/05/2023 | 8:00PM | GlobeNewswire Inc. | Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics | NASDAQ:OLK | Olink Holding AB |
| 10/31/2023 | 11:36AM | Edgar (US Regulatory) | Form SC 14D9 - Solicitation, recommendation statements | NASDAQ:OLK | Olink Holding AB |
| 10/25/2023 | 8:00AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:OLK | Olink Holding AB |
| 10/18/2023 | 5:30PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:OLK | Olink Holding AB |
| 10/17/2023 | 6:40PM | Business Wire | Thermo Fisher Scientific prépare l'acquisition d'Olink, leader de la protéomique de nouvelle génération | NASDAQ:OLK | Olink Holding AB |
| 10/17/2023 | 6:39PM | Business Wire | Thermo Fisher Scientific übernimmt Olink, ein führendes Unternehmen der Proteomik der nächsten Generation | NASDAQ:OLK | Olink Holding AB |
| 10/17/2023 | 5:28PM | Edgar (US Regulatory) | Form SC14D9C - Written communication relating to third party tender offer | NASDAQ:OLK | Olink Holding AB |
| 10/17/2023 | 10:16AM | Dow Jones News | Olink Holding Shares Soar on Takeover by Thermo Fisher | NASDAQ:OLK | Olink Holding AB |
| 10/17/2023 | 9:01AM | Dow Jones News | Thermo Fisher to Buy Olink in $3.1 Billion Deal | NASDAQ:OLK | Olink Holding AB |